Company / Total Assets
Harmony Biosciences Holdings, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.3B
FY2025
5-year range
$433.4M / $1.3B
FY2021-FY2025
Trend
+27.3%
vs FY2024
Sector context
#65 of 214
Health Care
What the data says
At $1.3B, Harmony Biosciences Holdings, Inc.'s total assets ranks #65 of 214 in the Health Care sector. Total Assets has increased for 6 consecutive years, from $107M in FY2019 to $1.3B in FY2025.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +24.4%.
Improved from $811M to $1.3B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +23.6%
- 5-Year CAGR
- +24.4%
- 10-Year CAGR
- -
Sector benchmark
#65 of 214 in Health CareTop 30% of 214This company $1.3B Sector average $7.5B
▼
-83.0% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s total assets has grown for 6 consecutive years.
- 5-year CAGR of +24.4%, indicating consistent growth.
- In FY2025, total assets increased 27.3% year-over-year.
- Ranks #65 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +27.3% |
| FY2024 | $999.2M | +23.1% |
| FY2023 | $811.4M | +20.4% |
| FY2022 | $673.9M | +55.5% |
| FY2021 | $433.4M | +1.5% |
| FY2020 | $427.1M | +300.2% |
| FY2019 | $106.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026